The Karyotype Test is a fundamental genetic analysis in fertility assessment. It allows for the detection of alterations in the number or structure of chromosomes that can cause infertility, recurrent miscarriages, congenital malformations, or developmental delay. These anomalies are responsible for up to 50% of spontaneous miscarriages in the first trimester.
The Karyotype Test allows for the detection of genetic alterations that may be affecting your fertility or causing recurrent miscarriages. It is an essential test before initiating an assisted reproduction treatment, as it provides a clear diagnosis and helps personalize the medical approach.
This study identifies chromosomal anomalies that often present no symptoms but directly influence conception and embryonic development. Furthermore, it allows for the prevention of transmitting genetic alterations to offspring, enabling safer and more effective medical decisions.
The Karyotype Test has a direct application in the diagnosis and treatment of infertility. Its analysis allows for the identification of chromosomal alterations that may be interfering with reproductive capacity or causing early miscarriages.
With this information, the medical team can anticipate issues, apply preventive strategies, and design personalized treatments, improving success rates in assisted reproduction techniques and reducing the risk of genetic transmission to offspring.
➔ Greater diagnostic clarity prior to fertility treatments
➔ Precise medical guidance based on your genetic profile
➔ Personalized support from our expert team
➔ Better clinical decisions, higher probability of reproductive success
➔ Couples with recurrent miscarriages or infertility.
➔ Couples about to undergo an assisted reproduction procedure.
➔ Cases of congenital malformations.
➔ Cases of developmental delay.
The Karyotype Test is recommended in cases of infertility, recurrent miscarriages, congenital malformations, developmental delay, or prior to initiating an assisted reproduction treatment. Detecting potential genetic alterations allows for better treatment guidance and increases the chances of reproductive success.
To perform the test, a peripheral blood sample collected in heparin tubes is required. It is a non-invasive, easily obtained procedure performed by our laboratory team. Sample collection requires no prior preparation or fasting.
Once collected, the sample is sent for processing to analyze alterations in the number or structure of chromosomes. The results will be sent to your physician along with a detailed result interpretation report.
The Karyotype Test allows for the identification of genetic alterations before clinical manifestation, facilitating early medical intervention. Its use in preventive medicine helps reduce reproductive risks, plan safe pregnancies, and prevent the transmission of chromosomal anomalies to offspring.
